This could be as impactful as the discovery of penicillin
Why haven’t you heard of him? Because he’s dedicated to science, not sales. So, what do scientists and entrepreneurs have in common? They both dedicate their lives to making a difference, discovering ways to make the world operate more effectively. But there’s an important cultural distinction between the two: Entrepreneurs’ success is tied to dollars, while scientists’ success is tied to discovery.
Remember how penicillin altered history? We might be at that moment in history again, but with a “ketone ester” drink invented by Dr. Veech, that has insanely widespread uses. Imagine a drink that could treat Alzheimer’s, Parkinson’s, diabetes, epilepsy, concussions, heart failure, all while helping elite endurance athletes break world records. Then, imagine that it’s a formula perfected over decades, but only now ready in an era where genetics is sexiest of sciences, so this liquid goes underfunded and underproduced. It seems too good to be true, but it’s not. It’s real.
Add to the issue of funding is an overly modest old scientist who said he would literally run if someone called him a hero for his work.
Next, toss in imitation products that use salt-filled caffeinated versions of Dr. Veech’s decades old, already discarded work and you might be left very confused. If a breakthrough sports drink and patient treatment exists, would anyone even believe it?
So what is this ketone ester?
Ketones are human’s back up fuel system that kicks in when humans starve, or at least run out of sugar. The body then burns fat to create an efficient ketone fuel. What many of the therapeutic uses (including Alzheimer’s) have in common is the brain’s blockage of the path to use sugar for energy, meanwhile ketones can bypass this blockage and simply fuels the brain.
Dr. Veech invented a way to bottle that fuel, in a fat-free and salt-free super FDA-approved concentrated food, not a drug. Ketosis is the metabolic state that uses ketones as a primary fuel source, but is mainly known by those that undergo an Atkin-like ketogenic high fat diet. This is drastically different because you get the benefits of ketones without the drawbacks of the high fat. Some call the fat-free version of ketosis, “Veetosis,” in honor of Dr. Veech, the doctor who holds the key to so many treatments.
The catch is that even though billions can be made from this invention, it is unbelievably expensive to make and there’s no funding for an older scientist that doesn’t schmooze. How expensive? For scientific purposes, labs can make a patented product, and for this exact ester they charge $60,000 per 25 mL serving, but with a newly discovered process and an investment, that could drop quickly to $20 a drink.
Absent a single investment, perhaps that can be done via the new world of crowdfunding (or rich, science-inclined geeky startup folks), so hopefully you’ll see Dr. Veech’s ketone ester on shelves sooner rather than later.
The path to the discovery has been long
Dr. Veech worked in 1966 with Dr. Cahill (the man that starved volunteers to prove the brain could run on ketones), and in 1969 under nobel laureate Dr. Krebs (if you took chemistry, you have definitely heard of the Krebs cycle). Dr Veech solved a problem which Krebs delegated to him. Krebs said he must be wrong, only to come back later to co-author the longest paper of Krebs’ career. It was the foundation for understanding why ketones work. Right now, our science geek readers get it – Dr Veech is a pretty big deal, and his work should be taken seriously.
Fast forward to 1995, Dr. Veech co-authored a breakthrough paper on how ketones change metabolism, and in 2000, a paper on Parkinson’s, Alzheimer’s, diabetes, and abolishing the effects of free radical damage.
In 2004, as part of a competition to find a new fuel for the special forces, the U.S. Defense Advanced Research Projects Agency (DARPA), gave a handful of groups $2 million each per year. Only Dr Veech’s group, including Oxford University partner Dr. Kieran Clarke, was left standing. They earned $10 million of total funding, resulting in an FDA-approved food. Who would have guessed DARPA’s role in potentially treating millions of patients with this new food?
A modest scientist does not a salesman make
Even a simple Oxford-approved boxing study to demonstrate ketone ester’s benefits for concussions hasn’t been picked up. One would think a football team owner might want to donate to prove a treatment backed by science that may bring a $20 million a year quarterback that has been earholed, back onto the field a few games earlier. Not to mention, the league could limit the potential liability around debilitating diseases plaguing players decades later.
So the path to the discovery has been long, but anyone we spoke to that was aware of Dr. Veech’s work sung his praises. The challenge is that the older sharp-tongued doctor is hyper-focused on his work, isn’t interested in fame, noting that it is “unseemly for doctors to promote themselves,” and that it is “not part of the job.” Times have changed, and modesty has been replaced by self promotion, as the driver in today’s world of discoveries.
Ketone esters have had success with human testing
In endurance sports, the ketone ester has been proven in a lab to increase output by up to 2%. That can be the difference between a gold and not placing. When tested on 19 elite rowers, there were nine season’s bests, five personal bests and one world record. Only one did slightly worse than the placebo test.
Meanwhile, Dr. Mary Newport was trying to treat her husband with Alzheimer’s and discovered Dr. Veech’s work while digging around in his 20+ patents. She was the author of “Alzheimer’s Disease What If There Was a Cure, The Story of Ketones” about her coconut oil therapy that naturally releases ketones, which she said turned her husband’s “lights back on.” Hundreds have written to her claiming similar results. Ultimately, her husband received Dr. Veech’s ketone ester for a few years and Dr. Newport said it was 10x more effective than the coconut therapy.
Think about that for a minute. The lights came back on! Why is the world not freaking out with excitement!?
Another believer in ketones and Dr. Veech is William Curtis. He has had Parkinson’s for over 15 years, and despite being on the common cocktail of meds, he had tremors, severe muscle spasms, and sometimes stared at the computer screen for hours, nearly frozen. With a little biochem in undergrad, he searched and came across Dr. Veech’s papers, emailed with the doctor, and sought alternative natural ways to raise his ketone levels (also referred to as D-bhb levels).
Dr. Veech told him that absent the availability of clinical trials with the ester, and as long as his primary care doctor approved, Curtis could try a high fat morning drink to increase his ketone levels. After some tweaks and fasting each night, Curtis says his results were stellar. He could concentrate for hours, spasm free, and was able to drive again. Dr. Veech has warned Curtis to watch his cholesterol and to stay on his meds. Curtis continues his routine today, shares his successes online, and plans to continue until the ketone ester is available in clinical trials.
This generation’s most significant medical discovery
The final problem is that scientists write papers and seek grants which don’t require a monetary return on investment; for many it’s just not in their nature to write a business plan and go to a bunch of pitch offs.
We believe that with billions being thrown at sciences like space travel, it seems that investors or Congress should be primed to pump a few dollars into a simple ester to treat a dozen common medical problems that impact all of us as individuals and is nearly bankrupting the country.
We will be following Dr. Veech’s progress (he even finally has his own website), and works as he blazes a path in the scientific community, and hopefully soon, the business community. It is our sincere hope that investors (both government, traditional, and non-traditional) “read the damn papers,” as Dr. Veech says, because we believe that he’s sitting on our generation’s equivalent of the discovery of penicillin. If not bigger.
UPDATE: Dr. Veech is now on Twitter so you can connect with him.
Chasing Clubhouse success? How the audio chat room trend affects products
(BUSINESS NEWS) It is inevitable that when a new successful trend comes along, other companies will try to make lightning strike twice. Will the audio chat room catch on?
Businesses are always about the hot new thing. People are the always looking for the easiest dollar with the least amount of effort these days. It tends to lead to products that are shoddy and horribly maintained with the least amount of flexibility in pleasing their customers. However, you also have to look at the customer base for this as well. You follow where the money is because that’s where its being spent. It’s like a merry-go-round, constantly chasing the next thing. And the latest of these is the audio chat room.
During the pandemic the entire world saw an eruption of social audio investments. Silicon Valley has gone crazy with this new endeavor. On the 18th of April this year, Clubhouse said it closed on some new funding, which was valued at $4 billion for a live audio app. This thing is still in beta without a single penny of revenue!
The list of other companies who have pursued new audio suites (either through purchase or creation) include:
This whole new audio fad is still in its infancy. These social media and tech giants are all jumping headlong into it with who knows how much forethought. A number of them have their own issues to deal with, but they’ve put things aside to try and grab these audio chat room coattails that are running by. It’s a mix of feelings about the situation honestly. They are trying to survive and keep their customers.
If a competitor creates this new capability and they stay stagnant then they lose customers. If they do this however without dealing with their current issues then they could also lose people. It’s an interesting catch 22 for people out there. Which group do you fall in? Are you antsy for a new toy or are you waiting for one of these lovely sites to fix a problem? It’s another day in capitalism.
This web platform for cannabis is blowing up online distribution
(BUSINESS NEWS) Dutchie, a website platform for cannabis companies, just octupled in value. Here’s what that means for the online growth of cannabis distribution.
The cannabis industry has, for the most part, blossomed in the past few years, managing to hit only a few major snags along the way. One of those snags is the issue of payment processing, an issue compounded by predominantly cash-only transactions. Dutchie, a Bend, Oregon company, has helped mitigate that issue—and it just raised a ton of money.
Technically, Dutchie is a jack-of-all-trades service that creates and hosts websites for dispensaries, tracks product, processes orders, keeps stock of revenue, and so much more. While it was valued at around $200 million as recently as summer of 2020, a round of series C funding currently puts the company at around $1.7 billion—approximately 8 times its worth a mere 8 months ago.
There are a few reasons behind Dutchie’s newfound momentum. For starters, the pandemic made cannabis products a lot more accessible—and desirable—in states in which the sale of cannabis is legal. The ensuing surge of customers and demand certainly didn’t hurt the platform, especially given that Dutchie is largely responsible for keeping things on track during some of the more chaotic months for dispensaries.
Several states in which the sale of cannabis was illegal also voted to legalize recreational use, giving Dutchie even more stomping ground than they had prior to the lockdown.
Dutchie also recently took on 2 separate companies and their associated employees, effectively doubling their current staff. The companies are Greenbits—a resource planning group—and Leaflogix, which is a point-of-sale platform. With these two additions to their compendium, Dutchie can operate as even more of an all-in-one suite, which absolutely contributes to its value as a company.
Ross Lipson, who is Dutchie’s co-founder and current CEO, is fairly dismissive of investment opportunities for the public at the moment, saying he instead prefers to stay “focused with what’s on our plate” for the time being. However, he also appears open to the possibility of going public via an acquisition company.
“We look at how this decision brings value to the dispensary and the customer,” says Lipson. “If it brings value, we’d embark on that decision.”
For now, Dutchie remains the ipso facto king of cannabis distribution and sales—and they don’t show any plans to slow down any time soon.
Ford adopts flexible working from home schedule for over 30k employees
(BUSINESS NEWS) Ford Motor Co. is allowing employees to continue working from home even after the pandemic winds down. Is this the beginning of a trend for auto companies?
The pandemic has greatly transformed our lives. For the most part, learning is being conducted online. At one point, interacting with others was pretty much non-existent. Working in the office shifted significantly to working remotely, and it seems like working from home might not go away anytime soon.
As things slowly get back to a new “normal”, will things change again? Well, one thing is sure. Working from home will be a permanent thing for some people as more companies opt to continue letting people work remotely.
And, the most recent company on the list to do this is Ford Motor Co. Even after the pandemic winds down, Ford will allow more than 30,000 employees already working from home to continue doing so.
Last week, the automaker giant announced its “flexible hybrid model” schedule to its staff. The new schedule is set to start in the summer, and employees can choose to work remotely and come into the office for tasks that require face-to-face collaborations, such as meetings and group projects.
How much time an employee spends in the office will depend on their responsibilities, and flexible remote hours will need to be approved by an employee’s manager.
“The nature of work drives whether or not you can adopt this model. There are certain jobs that are place-dependent — you need to be in the physical space to do the job,” David Dubensky, chairman and chief executive of Ford Land, told the Washington Post. “Having the flexibility to choose how you work is pretty powerful. … It’s up to the employee to have dialogue and discussion with their people leader to determine what works best.”
Ford’s decision to implement a remote-office work model has to do in part with an employee survey conducted in June 2020. Results from the survey showed that 95% of employees wanted a hybrid schedule. Some employees even reported feeling more productive when working from home.
Ford is the first auto company to allow employees to work from home indefinitely, but it might not be the only one. According to the Post, Toyota and General Motors are looking at flexible options of their own.
Opinion Editorials1 week ago
3 things to do if you *really* want to be an ally to women in tech
Business Marketing2 days ago
Video is necessary for your marketing strategy
Opinion Editorials2 weeks ago
Questions you wished recruiters would answer
Tech News2 days ago
Chatbots: Are they still useful, or ready to be retired?
Business Entrepreneur1 week ago
15 tips to spot a toxic work environment when interviewing
Opinion Editorials1 week ago
4 simple tips to ease friction with your boss while working remotely
Business Entrepreneur2 weeks ago
Zen, please: Demand for mental health services surges during pandemic
Opinion Editorials6 days ago
Why robots freak us out, and what it means for the future of AI